title: Heart failure in the Middle East.
abstract: The clinical syndrome of heart failure is the final pathway for a myriad of diseases that affect the heart, and is a leading and growing cause of morbidity and mortality worldwide. Evidence-based guidelines have provided clinicians with valuable data for better applying diagnostic and therapeutic tools, particularly the overwhelming new imaging technology and other, often expensive, therapies and devices, in heart failure patients. In the Middle East, progress has recently been made with the development of regional and multi-centre registries to evaluate the quality of care for patients with heart failure. A new heart function clinic recently began operation and has clearly resulted in a reduced readmission rate for heart failure patients. Many Middle Eastern countries have observed increases in the prevalence of the risk factors for the development of heart failure, including diabetes mellitus, obesity, and hypertension, with heart failure in the Middle Eastern population developing earlier than it is in their Western counterparts by at least 10 years. The earlier onset of disease is the result of the earlier onset of coronary artery disease, highlighting the need for Middle Eastern countries to establish prevention programs across all age groups. The health systems across the Middle East need to be modified in order to provide improved evidence-based medical care. Existing registries also need to be expanded to include long-term survey data, and additional funding for heart failure research is warranted.
authors.affiliation: Department of Cardiac Science, King Fahad Cardiac Center, King Khalid University Hospital, King Saud University, Riyadh, Kingdom of Saudi Arabia. mshamiri@hotmail.com
authors.forename: Mostafa Q
authors.initials: MQ
authors.lastname: Al-Shamiri
mesh_terms: D015984:Causality; D015897:Comorbidity; D003327:Coronary Disease / Q000453:epidemiology; D006333:Heart Failure / Q000145:classification / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy; D006801:Humans; D008877:Middle East / Q000453:epidemiology; D015995:Prevalence; D011379:Prognosis; D012307:Risk Factors